Dark
Light
System
Institutional Investment Manager
Broadfin Capital, LLC
Broadfin Capital, LLC (CIK: 0001511901) incorporated in Delaware, located at 300 Park Avenue, 25th Floor, New York, NY. Institutional holdings reported to the SEC.

Institutional Holdings (2016Q1)
Portfolio Summary: 71 holdings with a total value of $1,035,404,000.
#
Name
Shares
Value ($)
%
Options
Notes
1 HORIZON PHARMA PLC 6,823,377 113,063,000 10.92%
2 ISHARES TR 1,000,000 110,630,000 10.68% Put
3 NOVADAQ TECHNOLOGIES INC 5,465,216 60,609,000 5.85%
4 FLAMEL TECHNOLOGIES SA SPONSORED ADR 4,394,464 48,515,000 4.69%
5 RETROPHIN INC COM 2,959,790 40,431,000 3.90%
6 PROGENICS PHARMACEUTICALS IN 8,951,169 39,027,000 3.77%
7 NEVRO CORP 667,907 37,576,000 3.63%
8 RAPTOR PHARMACEUTICAL CORP 7,000,000 32,200,000 3.11%
9 ANGIODYNAMICS INC 2,498,527 30,707,000 2.97%
10 HERON THERAPEUTICS INC 1,465,475 27,829,000 2.69%
11 HORIZON PHARMA PLC 1,500,000 24,855,000 2.40% Call
12 LA JOLLA PHARMACEUTICAL CO 1,165,373 24,368,000 2.35%
13 Anacor Pharmaceuticals Inc 400,000 21,380,000 2.06% Call
14 ARATANA THERAPEUTICS INC COM 3,428,865 18,927,000 1.83%
15 NEVRO CORP 300,000 16,878,000 1.63% Call
16 BioDelivery Sciences International Inc 5,188,794 16,760,000 1.62%
17 IGNYTA INC COM 2,256,546 15,277,000 1.48%
18 ADVAXIS INC COM NEW 1,690,517 15,265,000 1.47%
19 CARDIOVASCULAR SYS INC DEL COM 1,462,663 15,168,000 1.46%
20 AEGERION PHARMACEUTICALS INC 4,010,291 14,838,000 1.43%
21 SEASPINE HLDGS CORP COM 1,000,007 14,640,000 1.41%
22 ARALEZ PHARMACEUTICALS INC 3,800,000 13,490,000 1.30%
23 MEDGENICS INC 3,045,306 13,399,000 1.29%
24 ANTARES PHARMA INC 15,085,393 13,126,000 1.27%
25 SOCIETAL CDMO INC 2,060,086 12,299,000 1.19%
26 TELIGENT INC NEW 2,287,728 11,210,000 1.08%
27 Lion Biotechnologies 2,105,519 10,696,000 1.03%
28 DYNAVAX TECHNOLOGIES CORP 547,810 10,540,000 1.02%
29 Redhill Biopharma Ltd 818,265 10,024,000 0.97%
30 CATALYST PHARMACEUTICALS INC 8,200,000 9,594,000 0.93%
31 QLT INC 4,445,527 8,847,000 0.85%
32 ENDOLOGIX INC 1,000,000 8,360,000 0.81%
33 ZOGENIX INC 882,312 8,153,000 0.79%
34 PARATEK PHARMACEUTICALS INC 530,282 8,044,000 0.78%
35 DERMA SCIENCES INC COM PAR .01 2,562,104 7,943,000 0.77%
36 ADMA BIOLOGICS, INC. 964,193 7,800,000 0.75%
37 Egalet Corp 1,134,750 7,784,000 0.75%
38 Strongbridge Biopharma plc 1,656,705 7,555,000 0.73%
39 XENOPORT INC 1,592,067 7,180,000 0.69%
40 AMARIN CORP PLC 4,675,216 7,153,000 0.69%
41 CORIUM INTERNATIONAL INC 1,802,092 6,956,000 0.67%
42 TREVENA INC 812,579 6,720,000 0.65%
43 PERNIX THERAPEUTICS HLDGS IN 6,090,829 6,395,000 0.62%
44 SYNERON MEDICAL LTD ORD SHS 870,013 6,360,000 0.61%
45 IDERA PHARMACEUTICALS INC 3,094,745 6,128,000 0.59%
46 ALCOBRA LTD 1,557,106 5,901,000 0.57%
47 Anacor Pharmaceuticals Inc 100,000 5,345,000 0.52%
48 PERNIX THERAPEUTICS HLDGS IN 15,500,000 5,287,000 0.51%
49 BIOTA PHARMACEUTIALS INC COM 3,486,711 5,230,000 0.51%
50 Dipexium Pharmaceuticals Inc 465,978 4,431,000 0.43%
Page 1 of 2

Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000919574-16-013079, filed 2016.05.16).

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.